Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 3
2020 7
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Kabelitz D, et al. Among authors: kouakanou l. Cell Mol Immunol. 2020 Sep;17(9):925-939. doi: 10.1038/s41423-020-0504-x. Epub 2020 Jul 22. Cell Mol Immunol. 2020. PMID: 32699351 Free PMC article. Review.
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.
Xu Y, Xiang Z, Alnaggar M, Kouakanou L, Li J, He J, Yang J, Hu Y, Chen Y, Lin L, Hao J, Li J, Chen J, Li M, Wu Q, Peters C, Zhou Q, Li J, Liang Y, Wang X, Han B, Ma M, Kabelitz D, Xu K, Tu W, Wu Y, Yin Z. Xu Y, et al. Among authors: kouakanou l. Cell Mol Immunol. 2021 Feb;18(2):427-439. doi: 10.1038/s41423-020-0515-7. Epub 2020 Sep 16. Cell Mol Immunol. 2021. PMID: 32939032 Free PMC article.
In vitro expansion of Vγ9Vδ2 T cells for immunotherapy.
Peters C, Kouakanou L, Oberg HH, Wesch D, Kabelitz D. Peters C, et al. Among authors: kouakanou l. Methods Enzymol. 2020;631:223-237. doi: 10.1016/bs.mie.2019.07.019. Epub 2019 Jul 24. Methods Enzymol. 2020. PMID: 31948549
TGF-β enhances the cytotoxic activity of Vδ2 T cells.
Peters C, Meyer A, Kouakanou L, Feder J, Schricker T, Lettau M, Janssen O, Wesch D, Kabelitz D. Peters C, et al. Among authors: kouakanou l. Oncoimmunology. 2018 Sep 26;8(1):e1522471. doi: 10.1080/2162402X.2018.1522471. eCollection 2019. Oncoimmunology. 2018. PMID: 30546961 Free PMC article.
Reply to: Vitamin C as a promoter of γδ T cells.
Kouakanou L, Peters C, Kabelitz D. Kouakanou L, et al. Cell Mol Immunol. 2021 Feb;18(2):495. doi: 10.1038/s41423-020-00622-3. Epub 2021 Jan 12. Cell Mol Immunol. 2021. PMID: 33437051 Free PMC article. No abstract available.
13 results